ToffCap on X
$MRX Q2: +39% revenue growth, 17% PAT margin (cont ops), 37% ROE, ~$2 EPS growing 100%+, mgt guiding further strong growth... Still 8.5x annualised PE https://t.co/ihSaFMMBLO
Search
Every article we have published, filed by the company it is actually about.
1807 articles about companies over $300M
$MRX Q2: +39% revenue growth, 17% PAT margin (cont ops), 37% ROE, ~$2 EPS growing 100%+, mgt guiding further strong growth... Still 8.5x annualised PE https://t.co/ihSaFMMBLO
$ITRN is pristine (was $36 at the time of this post). It’s $55 today, up $3 on a solid Q2. The moron I am, I still haven’t bought. The valuation was never “perfect.” Some things are just worth paying up for. I do see a path to $100. Lesson👉 InfoArb exists even outside microcaps. https://t.co/kJghFGxAph
I'm short a little $CRWV. Obviously I'm not happy with the move today, but I listened to the @cnbc interview with the CEO and two things really made me feel better: 1) @jimcramer called it an "inflection point" and a day that will go down in history (thank you for your tireless service Jim) 2) The $CRWV CEO's stuttering and non-stuttering sequences really were quite revealing. I'm not trying to belittle someone's speech challenges. Public speaking is hard, but someone with some basic CIA interview skills training would have a field day with his 5-10 minute segment on CNBC, particularly when asked about margins, insider selling, and project delays. He struggled mightily there to get the words out, which is telling. Of course @CNBC clipped out most of those parts of the interview, but you can watch the rest here. https://t.co/ldWzhWZXlO
@kingdomcapadv posted a good $EVC write up on Seeking Alpha this morning. https://t.co/k96glqoOiQ
Solid results from Marex $MRX yet again. Strong beat + in the portfolio. That means the stock will probably close 20% down today https://t.co/8EYa8jlUHZ
Bernstein China Semicap & WFE update: $101 bn in ‘28 > WFE ramp drives reacceleration of local WFE vendors > logic underestimated > memory revised up: CXMT, YM & JHICC easier to ramp clean rooms > local vendors take share from global vendors > ‘27-28 numbers go up $ACMR https://t.co/8qZFoulEau
Stride’s $LRN CEO James Rhyu seems to be getting canned and will be replaced by old-timer Robert Knowling. Is the 71-year-old CEO the right person to run a company that’s struggling with tech implementations, or is he better suited to manage relations with school boards? To calm the markets, LRN pre-released earnings in line with expectations, but they failed to comment on enrollment figures, which spooked markets. This has been a volatile name. If they guide to a return to growth in Q1, this should re-rate from the 9x FCF it currently trades at. If for some reason enrollments decline because parents are holding a grudge after a year of tech issues, watch out below. Operating leverage is very strong here. Mr. Knowling’s contract includes a change-of-control provision.
Market doesn't care for $PAGS earnings. I thought they were fine. Still long and may add. https://t.co/00u7Uy3BOO
Entravision’s ATS revenue rose 230% to $182.8 million in Q2, but shares fell from above $14 to about $8 after management forecast…
Me, I bought this crap (around $21.4). $SMCI https://t.co/yRsywgjrZw
Can’t say there’s any slam dunk information arbitrage out of @InfoArbMonitor last batch of Delta Sheets, but there’s still a few interesting tid bits. $ASYS and $PAYS are not crazy cheap, but could be on future numbers. $NNBR probably has the best momentum, but they just went through some massive dilution. $ASYS might be my favorite out of the bunch. Thinking about buying it back at some point.
@eager28 No I’m invested indirectly via $SKM
UWM suspended its dividend and took an Oaktree rescue after a $603 million rate-derivatives loss, following $3 billion in payouts to CEO…
I think $MELI's up for same reason $SE's up. Signs that Sea's reinvestment cycle is turning (or least not as aggressive as feared - see the 2H ebitda guide), which means less pressure on MELI. And maybe MELI margins have found a bottom / will inflect soon too. + Just maybe, both can co-exist & grow 50% y/y.
For FY 2027, the Company expects net sales in the range of $65.0 billion to $72.0 billion. Net sales in the range of $14.5 billion & $15.5 billion for the first quarter of FY 2027 ending September, 2026, and non-GAAP net income per diluted share of $1.01 to $1.10 $SMCI 👀 https://t.co/BMrEvmCbQj
@Ghostlike @TheOneLanceB You’re missing critical context on my $AMZN trade. If you care to dig in, start with my high-level breakdown on this week’s @TheICHpodcast.
Sea Limited reported Q2 2026 revenue of $7.8 billion, up 48%, as Shopee, Monee and Garena lifted adjusted EBITDA to $917 million.
@kingtutcap I know $VELO well any others to look at? Maybe something involved in missile production?
@shortbus_ace @akeemcap @QuietProsperity $CAAP is 6x EV/EBITDA and no Mexico. But half of EBITDA is from Argentina, so that's its own can of worms (albeit the Argy fees are charged at a fixed USD rate not Peso)
Entravision $EVC has $870 million market cap here. $944 million enterprise value. Ad-Tech based on guide will do around $160mm EBITDA. Media worth $300mm based on comps. Call option on $500mm of spectrum. Say spectrum is worth zero. Back out of media and you are buying this for 4.0x and no value to spectrum. Market saying big customer goes away completely here. I think that’s wrong.
@shortbus_ace @akeemcap @QuietProsperity Sheinbaum doesn't leave office until 2030 so that's a reasonable bet, though maybe you get clipped in 2029 once the pre-election hope cycle starts up. Underlying EBITDA will grow 12-15%/year like usual (faster at $ASR with the M&A) so stocks can still work in the interim.
$BWEL has been the most aggressive in years on its share buybacks since the last reported financials (6/30/25). While not as significant as I would like, the increased pace of buyback is probably a good sign for FY26 results. https://t.co/tQmmswZS0P
Bancolombia $CIB tags $100 today. Congrats to the Colombia bulls, market is heating up now. https://t.co/IQTMPVvWXf
Shift4 Payments trades at 6.9x EBITDA after a 50% five-year share decline, while leverage from acquisitions and slowing EPS growth weigh on…